通过脂质纳米粒子提供基于核酸的基因组编辑平台:临床应用

Razan Masarwy1, Lior Stotsky-Oterin2, Aviad Elisha1

  • 1Laboratory of Precision Nanomedicine, The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel; Department of Materials Sciences and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel; Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, Israel; School of Medicine, Tel Aviv University, Tel Aviv, Israel.

PubMed
概括

脂质纳米粒子 (LNP) 为CRISPR基因编辑疗法提供了一个有前途的输送方法. 优化LNP向对于癌症和遗传疾病等疾病的有效体内治疗至关重要.